RCOG/LinkedIn
Oct 13, 2026, 15:41
Cell-Free Fetal DNA Testing for Single-Gene Conditions – RCOG
Royal College of Obstetricians and Gynaecologists (RCOG) shared on LinkedIn:
“We have published a new Scientific Impact Paper on cell-free fetal DNA testing for single-gene conditions (Scientific Impact Paper No. 80).
Cell-free fetal DNA (cffDNA) circulates in a pregnant woman’s blood in early pregnancy and is a potential source of genetic material from the developing fetus that can be used to test the baby for selected genetic conditions.
This opinion paper reviews non-invasive prenatal diagnosis (NIPD) using cffDNA in specific single-gene conditions where it may be offered as an alternative to traditional invasive testing.
Other articles featuring RCOG on Fertility News.
-
Oct 13, 2026, 16:58Slavian Bumbu: A Low AMH Is Not an Infertility Diagnosis
-
Oct 13, 2026, 16:43Keshav Malhotra: No Embryologist or Laboratory Technique Can Guarantee Euploid Embryos
-
Oct 13, 2026, 16:37Tony Gordon: What Is the Most Successful Form of Fertility Treatment?
-
Oct 13, 2026, 16:29IVI RMA Global Introduces IVI Fertility
-
Oct 13, 2026, 16:12Devyanshi Dixit: PCOS May Be One Diagnosis, But Is It One Biological Disease?
-
Oct 13, 2026, 16:00Rajeev Agarwal: Age and Male Fertility, Through the PREPARE Method
-
Oct 13, 2026, 15:505 Years of the Patient Engagement Forum – HFEA
-
Oct 13, 2026, 15:24Somil Singhal: Method for Enhancing Embryo Implantation Using Embryo Glue and Its Importance
-
Oct 13, 2026, 15:06Clare Mansfield: Pregnancy Loss Is Grief, and Grief Looks Different for Everyone…